Sign In
Buy LLY
$1,131.42
+6.04 (+0.537%)
At Close: Jun 05, 2026
Lilly invests further $5.3 bln in new Indiana site as obesity drug demand soars
09:35am, Friday, 24'th May 2024
Eli Lilly said on Friday it has invested another $5.3 billion in its new Lebanon, Indiana manufacturing plant, more than doubling its previous investment, as it scrambles to meet soaring demand for it
Eli Lilly to invest another $5.3 billion in Indiana plant to expand Mounjaro, Zepbound supply
09:30am, Friday, 24'th May 2024
Eli Lilly said it is investing another $5.3 billion in a manufacturing plant in Lebanon, Indiana to expand the supply of its highly popular weight loss drug Zepbound, diabetes treatment Mounjaro and o
Largest investment in active pharmaceutical ingredient manufacturing of synthetic medicines in U.S. history Since 2020, the company has committed more than $18 billion to build, upgrade and acquire fa
Ozempic cuts kidney-disease risks, research finds
09:27am, Friday, 24'th May 2024
Novo Nordisk's diabetes drug Ozempic reduces the risk of kidney failure and death in patients who have both Type 2 diabetes and chronic kidney disease, according to new research published Friday in th
Eli Lilly to Spend $5.3 Billion to Make More Mounjaro, Zepbound
09:15am, Friday, 24'th May 2024
The outlay to expand an Indiana production site, combined with a previous $3.7 billion commitment, is the largest manufacturing investment in company history.
7 Stocks to Buy if the Market Ends Up Plunging
06:00am, Friday, 24'th May 2024
Stocks to buy if the market fails: that's the other side of the coin to the search query, is the market overvalued right now? Pop that question into your favorite search engine and you're bound to fin
Lilly Announces Details of Presentations at 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
05:00pm, Thursday, 23'rd May 2024
INDIANAPOLIS , May 23, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced that data from studies of Verzenio® (abemaciclib; a CDK4/6 inhibitor), Retevmo® (selpercatinib; a rearra
3 Biotech Stocks to Buy on the Dip: May 2024
02:01pm, Thursday, 23'rd May 2024
Biotech is one of the most exciting industries to invest in right now. Companies have drugs on the market worth billions and continue to strive to produce the newest and best treatments in modern medi
This up-and-coming cancer treatment could be a $25 billion market opportunity — it's already a hotbed for M&A
11:54am, Thursday, 23'rd May 2024
Targeted radiopharmaceuticals has caught the eye of big pharma. The therapy delivers radiation directly into tumors by attaching a radioactive particle to a targeting molecule.
3 Blue Chip Stocks That You Can Buy and Hold for Years
08:05am, Thursday, 23'rd May 2024
Walmart is a retail beast with an appetite for growth, which makes it likely this company won't just stand pat in the future. Apple's business showed signs of slowing last quarter, but artificial inte
Surprise: Eli Lilly Is Racing Toward Yet Another Blockbuster
06:45am, Thursday, 23'rd May 2024
Eli Lilly's once-weekly insulin product just aced phase 3 studies. The company will battle its eternal rival, Novo Nordisk, in this market.
Lilly (LLY) Hits Record High on Crohn's Disease Study Data
02:21pm, Wednesday, 22'nd May 2024
Eli Lilly's (LLY) stock hits an all-time high after announcing detailed results from a late-stage study on mirikizumab in Crohn's disease.
Amid ‘Ozempic babies' questions, women account for more than 75% of young adults taking GLP-1 drugs, study finds
11:04am, Wednesday, 22'nd May 2024
More than three out of four young adults prescribed GLP-1 drugs last year were women, new research shows, raising questions about how societal views of women's weight may influence use of these medica
Retire Rich: 3 Game-Changing Stocks to Own for the Next 10 Years
09:58am, Wednesday, 22'nd May 2024
Stock market investing offers wealth-building opportunities for those with a long-term investing time horizon. However, high rewards entail high risks, especially for those seeking quick gains.
BofA's Geoff Meacham talks Eli Lilly closing at record high
06:11pm, Tuesday, 21'st May 2024
Geoff Meacham, BofA Securities managing director, joins 'Closing Bell Overtime' to talk Eli Lilly closing at a record high and what's driving it higher.
